The global outbreak of mpox in 2022-23 affected more than 100 countries and grabbed the attention of the scientific community ...

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

Vaccine makers targeting COVID-19 to measles will come under investor scrutiny on Tuesday as a group of independent experts at the CDC are scheduled to meet for the first time to review U.S.

The National Medical Products Administration, China's top drug regulator, approved the vaccine for clinical trials in ...

China on Thursday reported an outbreak of monkeypox virus, specifically the Ib sub-branch, with four associated cases. The ...

A new report from GlobalData has raised concerns over the effectiveness of mpox vaccines for people living with HIV. Findings ...

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...

The novel antibiotic class could be active against the vast majority of multidrug-resistant Enterobacterales infections.

Jynneos was the first smallpox vaccine developed under Project BioShield, a program created by Congress in 2004 to accelerate ...

A recent study has shown that one dose of Bavarian Nordic’s Jynneos vaccine was overall 58% effective at preventing mpox ...

The formulation allows for greater stockpiling, with Bavarian Nordic already working with the US Government to add to vaccine reserves.